|
|
|
|
| Social Media |
|
Pharm Exec Global Digest Social Media Special |
| In the latest issue of Pharm Exec Global Digest: Has Pharma Finally ‘Got’ Social Media? — Five Ways Advanced Social Intelligence Can Guide Pharma Strategy — Preparing for Crisis in an ‘Always On’ Digital Word — and more ... /Read more/ |
|
ADVERTISEMENT
|
|
| Advertisement |
ZS Associates – Should You Pay the GSK Way?
GSK has been in the news frequently over the past three years with respect to changes in its incentive compensation program.
Should you consider a similar plan? |
|
| Employment survey |
|
|
Pharma Industry Optimism Outweighs Concerns for Job Security
|
|
Amid the environment of a gradual economic recovery and continued consolidation of bio/pharmaceutical companies, scientists, technicians, and professionals involved in drug development expressed muted optimism despite stagnant employment options in Pharmaceutical Technology’s latest employment survey ... /Read more/ |
|
|
|
|
Subscribers can enjoy each full issue of PharmExec in print, or via PharmExec apps. |
|
|
|
| Survey |
| What in your opinion poses the biggest threat to the industry over the next five years? |
|
|
|
| Advertisement |
 |
| Industry update |
| /Agilis Biotherapeutics (New York, NY) named George S. Zorich as the company’s new Chief Executive Officer.//ImmunoGen, Inc. (Waltham, MA) appointed David Johnston as Chief Financial Officer.//Halozyme Therapeutics, Inc. (San Diego, CA) announced that Helen Torley will be joining as President and Chief Executive Officer on January 6.//Wendell Wierenga, Ph.D, was appointed to the Board of Directors of Ocera Therapeutics, Inc. (Palo Alto, CA).// |
| Advertisement |
ZS Associates – Should You Pay the GSK Way?
GSK has been in the news frequently over the past three years with respect to changes in its incentive compensation program.
Should you consider a similar plan? |
|
|
|
|
|
